(PDF) Cost-Effectiveness of Sacubitril/Valsartan in the

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health - United Kingdom

doi 10.1016/j.jval.2017.08.1218

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2017

Authors

Publisher

Elsevier BV

Related search

Pcv82 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction in Singapore

Value in Health

Occupational Health

English

Pcv86 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure Under the Brazilian Private Healthcare System Perspective

Value in Health

Occupational Health

English

Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction: Cost and Effectiveness in the Italian Context

European Journal of Heart Failure

Cardiovascular Medicine

English

Pcv71 - Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Symptomatic Chronic Heart Failure With Reduced Ejection Fraction in Portugal

Value in Health

Occupational Health

English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure

Cardiovascular Medicine

English

Profile of Sacubitril/Valsartan in the Treatment of Heart Failure: Patient Selection and Perspectives

Vascular Health and Risk Management

English

Cv3 - Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold

Value in Health

Occupational Health

English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure

Cardiovascular Medicine

English

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - An Update

Basic and Clinical Pharmacology and Toxicology

English